Korea Investment Corp Eli Lilly & CO Transaction History

Korea Investment Corp

$41.3 Billion
Q3 2024

A detailed history of Korea Investment Corp transactions in Eli Lilly & CO stock. As of the latest transaction made, Korea Investment Corp holds 683,405 shares of LLY stock, worth $532 Million. This represents 1.47% of its overall portfolio holdings.

Number of Shares

683,405

Previous 696,623 1.9%

Holding current value

$532 Million

Previous $631 Million 4.0%

% of portfolio

1.47%

Previous 1.62%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $10.2 Million - $12.7 Million	-13,218 Reduced 1.9%	683,405 $605 Million
Q2 2024 Aug 13, 2024	BUY	$724.87 - $909.04 $1.52 Million - $1.9 Million	2,095 Added 0.3%	696,623 $631 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $14.2 Million - $19 Million	-23,922 Reduced 3.33%	694,528 $540 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $34.3 Million - $40.4 Million	-65,244 Reduced 8.33%	718,450 $419 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $13.3 Million - $18.3 Million	-30,519 Reduced 3.75%	783,694 $421 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $21.4 Million - $28.6 Million	-60,969 Reduced 6.97%	814,213 $382 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $5.42 Million - $6.36 Million	-17,444 Reduced 1.95%	875,182 $301 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $17.2 Million - $20.1 Million	53,536 Added 6.38%	892,626 $327 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $12.7 Million - $14.5 Million	42,898 Added 5.39%	839,090 $271 Million
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $3.03 Million - $3.56 Million	-10,864 Reduced 1.35%	796,192 $258 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $19.1 Million - $23.7 Million	81,353 Added 11.21%	807,056 $231 Million
Q4 2021 Feb 09, 2022	BUY	$224.85 - $279.04 $48.6 Million - $60.3 Million	216,193 Added 42.43%	725,703 $200 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $25.7 Million - $31.7 Million	-116,154 Reduced 18.56%	509,510 $118 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $25.3 Million - $32.8 Million	140,270 Added 28.9%	625,664 $144 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $19.7 Million - $25.5 Million	-120,086 Reduced 19.83%	485,394 $90.7 Million
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $3.84 Million - $5.08 Million	-29,405 Reduced 4.63%	605,480 $102 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $4.28 Million - $4.96 Million	-29,300 Reduced 4.41%	634,885 $94 Million
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $750,309 - $902,990	5,500 Added 0.83%	664,185 $109 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $18.4 Million - $22.7 Million	-154,300 Reduced 18.98%	658,685 $91.4 Million
Q4 2019 Feb 11, 2020	BUY	$106.92 - $132.43 $4.78 Million - $5.92 Million	44,700 Added 5.82%	812,985 $107 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $2.27 Million - $2.47 Million	-21,300 Reduced 2.7%	768,285 $85.9 Million
Q2 2019 Aug 12, 2019	BUY	$110.79 - $129.32 $875,241 - $1.02 Million	7,900 Added 1.01%	789,585 $87.5 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $2.32 Million - $2.73 Million	-20,872 Reduced 2.6%	781,685 $101 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $3.6 Million - $4.03 Million	-34,000 Reduced 4.06%	802,557 $92.9 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $1.98 Million - $2.47 Million	23,060 Added 2.83%	836,557 $89.8 Million
Q2 2018 Aug 13, 2018	BUY	$75.7 - $86.88 $1.83 Million - $2.1 Million	24,200 Added 3.07%	813,497 $0
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $13.1 Million - $15.5 Million	-176,771 Reduced 18.3%	789,297 $61.1 Million
Q4 2017 Feb 12, 2018	BUY	$81.94 - $87.89 $4.42 Million - $4.74 Million	53,927 Added 5.91%	966,068 $81.6 Million
Q3 2017 Oct 25, 2017	BUY	$77.07 - $85.54 $70.3 Million - $78 Million	912,141	912,141 $78 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.

Account

Korea Investment Corp Eli Lilly & CO Transaction History